FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1508550169> ?p ?o ?g. }

• W1508550169 endingPage "e0127761" @default.
• W1508550169 startingPage "e0127761" @default.
• W1508550169 abstract "According to previous investigations, CD14 is suggested to play a pivotal role in initiating and perpetuating the pro-inflammatory response during sepsis. A functional polymorphism within the CD14 gene, rs2569190, has been shown to impact the pro-inflammatory response upon stimulation with lipopolysaccharide, a central mediator of inflammation in sepsis. In this study, we hypothesized that the strong pro-inflammatory response induced by the TT genotype of CD14 rs2569190 may have a beneficial effect on survival (30-day) in patients with sepsis. A total of 417 adult patients with sepsis (and of western European descent) were enrolled into this observational study. Blood samples were collected for rs2569190 genotyping. Patients were followed over the course of their stay in the ICU, and the 30-day mortality risk was recorded as the primary outcome parameter. Sepsis-related organ failure assessment (SOFA) scores were quantified at sepsis onset and throughout the observational period to monitor organ failure as a secondary variable. Moreover, organ support-free days were evaluated as a secondary outcome parameter. TT-homozygous patients were compared to C-allele carriers. Kaplan-Meier survival analysis revealed a higher 30-day mortality risk among C-allele carriers compared with T homozygotes (p = 0.0261). To exclude the effect of potential confounders (age, gender, BMI and type of infection) and covariates that varied at baseline with a p-value < 0.2 (e.g., comorbidities), we performed multivariate Cox regression analysis to examine the survival time. The CD14 rs2569190 C allele remained a significant covariate for the 30-day mortality risk in the multivariate analysis (hazard ratio, 2.11; 95% CI, 1.08-4.12; p = 0.0282). The 30-day mortality rate among C allele carriers was 23%, whereas the T homozygotes had a mortality rate of 13%. Additionally, an analysis of organ-specific SOFA scores revealed a significantly higher SOFA-Central nervous system score among patients carrying the C allele compared with T-homozygous patients (1.9±1.1 and 1.6±1.0, respectively; p = 0.0311). In conclusion, CD14 rs2569190 may act as a prognostic variable for the short-term outcome (30-day survival) in patients with sepsis." @default.
• W1508550169 created "2016-06-24" @default.
• W1508550169 creator A5005110488 @default.
• W1508550169 creator A5008377302 @default.
• W1508550169 creator A5009037947 @default.
• W1508550169 creator A5014222629 @default.
• W1508550169 creator A5017187887 @default.
• W1508550169 creator A5017944645 @default.
• W1508550169 creator A5026578786 @default.
• W1508550169 creator A5028195752 @default.
• W1508550169 creator A5075057049 @default.
• W1508550169 creator A5088660111 @default.
• W1508550169 date "2015-05-28" @default.
• W1508550169 modified "2023-10-12" @default.
• W1508550169 title "The CD14 rs2569190 TT Genotype Is Associated with an Improved 30-Day Survival in Patients with Sepsis: A Prospective Observational Cohort Study" @default.
• W1508550169 cites W1672667089 @default.
• W1508550169 cites W1965245442 @default.
• W1508550169 cites W1968201338 @default.
• W1508550169 cites W1975275391 @default.
• W1508550169 cites W1982663159 @default.
• W1508550169 cites W1988331425 @default.
• W1508550169 cites W1991864206 @default.
• W1508550169 cites W1994656524 @default.
• W1508550169 cites W2007164727 @default.
• W1508550169 cites W2011073187 @default.
• W1508550169 cites W2019589274 @default.
• W1508550169 cites W2019952254 @default.
• W1508550169 cites W2020560849 @default.
• W1508550169 cites W2023448080 @default.
• W1508550169 cites W2024992082 @default.
• W1508550169 cites W2026170842 @default.
• W1508550169 cites W2041977750 @default.
• W1508550169 cites W2049927822 @default.
• W1508550169 cites W2053434429 @default.
• W1508550169 cites W2058352235 @default.
• W1508550169 cites W2067394045 @default.
• W1508550169 cites W2073578515 @default.
• W1508550169 cites W2083513831 @default.
• W1508550169 cites W2087203965 @default.
• W1508550169 cites W2094074380 @default.
• W1508550169 cites W2094530630 @default.
• W1508550169 cites W2137215362 @default.
• W1508550169 cites W2143803181 @default.
• W1508550169 cites W2144520945 @default.
• W1508550169 cites W2147383865 @default.
• W1508550169 cites W2157605375 @default.
• W1508550169 cites W2165005964 @default.
• W1508550169 cites W2275377917 @default.
• W1508550169 cites W2397254931 @default.
• W1508550169 cites W2581605534 @default.
• W1508550169 cites W3023757607 @default.
• W1508550169 doi "https://doi.org/10.1371/journal.pone.0127761" @default.
• W1508550169 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4447461" @default.
• W1508550169 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26020644" @default.
• W1508550169 hasPublicationYear "2015" @default.
• W1508550169 type Work @default.
• W1508550169 sameAs 1508550169 @default.
• W1508550169 citedByCount "15" @default.
• W1508550169 countsByYear W15085501692016 @default.
• W1508550169 countsByYear W15085501692017 @default.
• W1508550169 countsByYear W15085501692018 @default.
• W1508550169 countsByYear W15085501692019 @default.
• W1508550169 countsByYear W15085501692020 @default.
• W1508550169 countsByYear W15085501692021 @default.
• W1508550169 crossrefType "journal-article" @default.
• W1508550169 hasAuthorship W1508550169A5005110488 @default.
• W1508550169 hasAuthorship W1508550169A5008377302 @default.
• W1508550169 hasAuthorship W1508550169A5009037947 @default.
• W1508550169 hasAuthorship W1508550169A5014222629 @default.
• W1508550169 hasAuthorship W1508550169A5017187887 @default.
• W1508550169 hasAuthorship W1508550169A5017944645 @default.
• W1508550169 hasAuthorship W1508550169A5026578786 @default.
• W1508550169 hasAuthorship W1508550169A5028195752 @default.
• W1508550169 hasAuthorship W1508550169A5075057049 @default.
• W1508550169 hasAuthorship W1508550169A5088660111 @default.
• W1508550169 hasBestOaLocation W15085501691 @default.
• W1508550169 hasConcept C104317684 @default.
• W1508550169 hasConcept C10515644 @default.
• W1508550169 hasConcept C126322002 @default.
• W1508550169 hasConcept C135763542 @default.
• W1508550169 hasConcept C203014093 @default.
• W1508550169 hasConcept C2778384902 @default.
• W1508550169 hasConcept C50382708 @default.
• W1508550169 hasConcept C54355233 @default.
• W1508550169 hasConcept C71924100 @default.
• W1508550169 hasConcept C77350462 @default.
• W1508550169 hasConcept C86803240 @default.
• W1508550169 hasConceptScore W1508550169C104317684 @default.
• W1508550169 hasConceptScore W1508550169C10515644 @default.
• W1508550169 hasConceptScore W1508550169C126322002 @default.
• W1508550169 hasConceptScore W1508550169C135763542 @default.
• W1508550169 hasConceptScore W1508550169C203014093 @default.
• W1508550169 hasConceptScore W1508550169C2778384902 @default.
• W1508550169 hasConceptScore W1508550169C50382708 @default.
• W1508550169 hasConceptScore W1508550169C54355233 @default.
• W1508550169 hasConceptScore W1508550169C71924100 @default.
• W1508550169 hasConceptScore W1508550169C77350462 @default.
• W1508550169 hasConceptScore W1508550169C86803240 @default.

• next